caremark glp 1 CVS to cover Zepbound again after lawsuit, widespread backlash Well, this is infuriating. 📬,

Research has started to come out over the past couple years suggesting that these drugs could be a valuable tool to curb binges

"Big Pharma has spent the past 36 months using fear, misinformation, and regulatory pressure to paint compounding pharmacies as a public health threat

Evidence for hyperplasia (formation of new muscle fibers) needs even longer finding periods and specialized assessment techniques

Moreover, the method of administration (initially parenteral followed by oral in [54] versus oral only in [55]) and length of treatment (4 months in [54] versus 2 months in [55]) were different

Strategic Considerations for Companies in This Space Businesses that have exposure to GLP-1 compounds should take a careful and realistic look at their operations

NEJM, 2022